STAT – The Food and Drug Administration will soon be alerting companies that certain gene therapies in development can qualify for less arduous review at the agency.
The Detroit News – The nomination of President Trump’s pick to lead the National Highway Traffic Safety Administration is facing signs of trouble after a Senate committee postponed a Tuesday vote on whether her nomination should move forward.
The Daily Herald – The suspect was arrested for investigation of first-degree murder. He was determined to be the only potential suspect through a new forensic technology known as genetic genealogy.
The New York Times – The approval ushers in what many experts believe will be a new era in treatment for people who suffer the most severe form of these headaches.
The Washington Post – A federal appeals court found that restrictions against harming wildlife are inadequate for the controversial 600-mile natural gas project.
Healthcare Informatics – The Chief Data Strategist will engage with data-intensive research programs such as the All of Us Program, BRAIN Initiative, Cancer Moonshot, and Opioid Initiative.
Food and Drug Administration – The FDA approved Gilenya to treat relapsing multiple sclerosis in children and adolescents age 10 years and older. This is the first FDA approval of a drug to treat MS in pediatric patients.
MIT Technology Review – Saying the US is ahead of other nations in AI, the administration touts actions it has already taken to promote the technology.
The New York Times – The clinics remove fat from patients’ bellies and inject an extract of it into various parts of the body, on the theory that the extract contains stem cells that can provide replacement cells.
The Washington Post – The White House on Thursday plans to convene executives as it seeks to supercharge the deployment of powerful robots, algorithms and the broader field of artificial intelligence.